BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 23132903)

  • 1. A proposed modification to the McDonald 2010 criteria for the diagnosis of primary progressive multiple sclerosis.
    Kelly SB; Kinsella K; Duggan M; Tubridy N; McGuigan C; Hutchinson M
    Mult Scler; 2013 Jul; 19(8):1095-100. PubMed ID: 23132903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary progressive multiple sclerosis diagnostic criteria: a reappraisal.
    Montalban X; Sastre-Garriga J; Filippi M; Khaleeli Z; Téllez N; Vellinga MM; Tur C; Brochet B; Barkhof F; Rovaris M; Miller DH; Polman CH; Rovira A; Thompson AJ
    Mult Scler; 2009 Dec; 15(12):1459-65. PubMed ID: 19995843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of MRI of the brain and spinal cord, and CSF examination for the diagnosis of primary progressive multiple sclerosis.
    Nilsson P; Sandberg-Wollheim M; Norrving B; Larsson EM
    Eur J Neurol; 2007 Nov; 14(11):1292-5. PubMed ID: 17764461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary progressive multiple sclerosis: a comparative study of the diagnostic criteria.
    de Seze J; Debouverie M; Waucquier N; Steinmetz G; Pittion S; Zephir H; Fleury M; Blanc F; Vermersch P
    Mult Scler; 2007 Jun; 13(5):622-5. PubMed ID: 17548441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible new modifications for the McDonald 2010 criteria for the diagnosis of primary progressive multiple sclerosis.
    Tur C; Montalban X
    Mult Scler; 2013 Jul; 19(8):993-4. PubMed ID: 23818017
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of the 2010 McDonald multiple sclerosis criteria in children with a clinically isolated syndrome.
    Kornek B; Schmitl B; Vass K; Zehetmayer S; Pritsch M; Penzien J; Karenfort M; Blaschek A; Seidl R; Prayer D; Rostasy K
    Mult Scler; 2012 Dec; 18(12):1768-74. PubMed ID: 22526931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study.
    Filippi M; Preziosa P; Meani A; Ciccarelli O; Mesaros S; Rovira A; Frederiksen J; Enzinger C; Barkhof F; Gasperini C; Brownlee W; Drulovic J; Montalban X; Cramer SP; Pichler A; Hagens M; Ruggieri S; Martinelli V; Miszkiel K; Tintorè M; Comi G; Dekker I; Uitdehaag B; Dujmovic-Basuroski I; Rocca MA
    Lancet Neurol; 2018 Feb; 17(2):133-142. PubMed ID: 29275979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-world challenges in the diagnosis of primary progressive multiple sclerosis.
    Blok KM; Smolders J; van Rosmalen J; Martins Jarnalo CO; Wokke B; de Beukelaar J
    Eur J Neurol; 2023 Dec; 30(12):3799-3808. PubMed ID: 37578087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric onset multiple sclerosis: McDonald criteria 2010 and the contribution of spinal cord MRI.
    Hummel HM; Brück W; Dreha-Kulaczewski S; Gärtner J; Wuerfel J
    Mult Scler; 2013 Sep; 19(10):1330-5. PubMed ID: 23828866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary progressive multiple sclerosis: clinical and paraclinical characteristics with application of the new diagnostic criteria.
    Dujmović I; Mesaros S; Pekmezović T; Lević Z; Drulović J
    Eur J Neurol; 2004 Jul; 11(7):439-44. PubMed ID: 15257680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Revision of McDonald's new diagnostic criteria for multiple sclerosis].
    Wiendl H; Kieseier BC; Gold R; Hohlfeld R; Bendszus M; Hartung HP
    Nervenarzt; 2006 Oct; 77(10):1235, 1237-45. PubMed ID: 16912904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The reliability of specific primary progressive MS criteria in an ethnically diverse population.
    Ferreira Vasconcelos CC; Miranda Santos CM; Papais Alvarenga M; Camargo SM; Papais Alvarenga RM
    J Neurol Sci; 2008 Jul; 270(1-2):159-64. PubMed ID: 18474373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic significance of cerebrospinal fluid in multiple sclerosis.
    Siritho S; Freedman MS
    J Neurol Sci; 2009 Apr; 279(1-2):21-5. PubMed ID: 19181345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishing the diagnosis of multiple sclerosis in Croatian patients with clinically isolated syndrome: 2010 versus 2017 McDonald criteria.
    Habek M; Pavičić T; Ruška B; Pavlović I; Gabelić T; Barun B; Adamec I; Crnošija L; Krbot Skorić M
    Mult Scler Relat Disord; 2018 Oct; 25():99-103. PubMed ID: 30059896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The contribution of cerebrospinal fluid oligoclonal bands to the early diagnosis of multiple sclerosis.
    Zipoli V; Hakiki B; Portaccio E; Lolli F; Siracusa G; Giannini M; Pantoni L; Pescini F; Sorbi S; Amato MP
    Mult Scler; 2009 Apr; 15(4):472-8. PubMed ID: 19153171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MS, MRI, and the 2010 McDonald criteria: a Canadian expert commentary.
    Selchen D; Bhan V; Blevins G; Devonshire V; Duquette P; Grand'Maison F; Kremenchutzky M; Lapierre Y; Li D; von Riedemann SJ; Freedman M
    Neurology; 2012 Dec; 79(23 Suppl 2):S1-15. PubMed ID: 23212280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligoclonal bands and cerebrospinal fluid markers in multiple sclerosis: associations with disease course and progression.
    Lourenco P; Shirani A; Saeedi J; Oger J; Schreiber WE; Tremlett H
    Mult Scler; 2013 Apr; 19(5):577-84. PubMed ID: 22961214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.
    Thompson AJ; Banwell BL; Barkhof F; Carroll WM; Coetzee T; Comi G; Correale J; Fazekas F; Filippi M; Freedman MS; Fujihara K; Galetta SL; Hartung HP; Kappos L; Lublin FD; Marrie RA; Miller AE; Miller DH; Montalban X; Mowry EM; Sorensen PS; Tintoré M; Traboulsee AL; Trojano M; Uitdehaag BMJ; Vukusic S; Waubant E; Weinshenker BG; Reingold SC; Cohen JA
    Lancet Neurol; 2018 Feb; 17(2):162-173. PubMed ID: 29275977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lesion enhancement diminishes with time in primary progressive multiple sclerosis.
    Khaleeli Z; Ciccarelli O; Mizskiel K; Altmann D; Miller DH; Thompson AJ
    Mult Scler; 2010 Mar; 16(3):317-24. PubMed ID: 20203148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlations between structural CNS damage and functional MRI changes in primary progressive MS.
    Filippi M; Rocca MA; Falini A; Caputo D; Ghezzi A; Colombo B; Scotti G; Comi G
    Neuroimage; 2002 Mar; 15(3):537-46. PubMed ID: 11848696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.